Strong Demand For Shovels

Every drug, biologic and medical device company needs to conduct at least one clinical trial before it is allowed to market its product.  Increasingly, most also need to collect long-term outcomes through “post-market surveillance”.  As of April 15, 2024, there were over 491,000 clinical studies registered worldwide. ¹  

This does not include the many thousands of other studies in medical fields conducted by research organizations, medical societies, and academic medical centers.

Each of those studies requires data collection tools to capture, aggregate, report and analyze clinical and outcomes information.  As value-based care and real-world evidence become more important in healthcare, the need for these tools will greatly expand.  RegenMed’s Circles deliver to individual physicians — as well as to sophisticated industry clients – a regulatorily compliant, low cost, and highly efficient platform for any type of clinical study.

Plus, A Piece Of The Goldmine

Critically, each Circle can generate a clinically and statistically significant dataset proprietary to Circle Members and to RegenMed.  Such datasets represent significant and ongoing value for many potential healthcare constituencies.  RegenMed is not only selling shovels to the healthcare data gold miners, it is also helping them monetize their efforts while participating in that monetization.

‍